Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Aug;159(1):135-150.
doi: 10.1007/s11060-022-04051-2. Epub 2022 Jun 27.

Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis

Abdullah Egiz et al. J Neurooncol. 2022 Aug.

Abstract

Background: Gross total resection remains the gold-standard approach for vestibular schwannomas (VS) when surgery is indicated. In select cases, incomplete resection (IR) becomes a desired alternative to preserve the facial nerve function and the patient's quality of life. While a lot of earlier studies described incompletely resected sporadic VSs as dormant, more recent studies reported a higher growth rate following IR, therefore an evaluation of the residual VS growth rates could have important implications for the follow-up treatment protocols and provide relevant information for neurosurgeons, neuro-otologists, neuropathologists, and radiologists. Although prognostic factors predicting preoperative VS growth have been previously investigated, these factors have not been investigated following IR. Our review aims to examine the growth rate of residual sporadic VS following IR and to examine variables associated with the regrowth of residual VS.

Methods: The review was conducted in accordance with the PRISMA guidelines. Six databases (MEDLINE (Ovid), Embase (Ovid), CINAHL Plus (EBSCO), Cochrane Central Register of Controlled Trials (CENTRAL), WHO International Clinical Trials Registry Platform and UK Clinical Trials Gateway (WHO ICTRP) were searched. Full-text articles analysing growth rates in at least ten patients who had residual VS after IR were assessed. We conducted a meta-analysis using a random-effects model via RevMan.

Results: 14 studies totalling 849 patients were included in the analysis. The mean planimetric growth rate was 1.57 mm/year (range 0.16-3.81 mm/year). The mean volumetric growth rate was 281.725 mm3/year (range 17.9-530.0 mm3/year). Age, sex, pre-operative tumour size/volume, cystic tumour sub-type, MIB-1 index, and intracanalicular tumour location were not associated with residual growth. Residual tumour size/volume was statistically significant to growth (OR = 0.65, 95% CI 0.47-0.90, p = 0.01). Radiological re-growth occurred in an average of 26.6% of cases (range 0-54.5%).

Conclusion: From our analysis, only the residual tumour volume/size was associated with residual VS growth. Therefore, close postoperative surveillance for the first year, followed by an annual MRI scan for at least 5 years, and subsequently extended interval surveillance remains of utmost importance to monitor disease progression and provide timely surgical and adjuvant interventions. Our study shows that future work should be aimed at molecular and histological characteristics of residual VSs to aid prognostic understanding of growth.

Keywords: Incomplete resection; Meta-analysis; Recurrence; Surgery; Vestibular schwannoma.

PubMed Disclaimer

References

    1. Babu R, Sharma R, Bagley JH et al (2013) Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 119:121–130. https://doi.org/10.3171/2013.1.JNS121370 - DOI - PubMed
    1. Jeyakumar A, Seth R, Brickman TM, Dutcher P (2007) The prevalence and clinical course of patients with “incidental” acoustic neuromas. Acta Otolaryngol 127:1051–1057. https://doi.org/10.1080/00016480701200210 - DOI - PubMed
    1. Goldbrunner R, Weller M, Regis J et al (2020) EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol 22:31–45. https://doi.org/10.1093/neuonc/noz153 - DOI - PubMed
    1. Stangerup S-E, Tos M, Thomsen J, Caye-Thomasen P (2010) True incidence of vestibular schwannoma? Neurosurgery 67:1335–1340 - DOI
    1. Ostrom QT, Gittleman H, Liao P et al (2017) CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the united states in 2010–2014. Neuro Oncol 19:v1–v88. https://doi.org/10.1093/neuonc/nox158 - DOI - PubMed - PMC

LinkOut - more resources